Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
Radiopharmaceuticals imply the usage of radiation for non-invasive treatment and diagnosis of various diseases. Utilization of these molecules for medical purposes in PET and SPECT imaging has changed the entire algorithm of disease diagnosis. With rise in the aging population globally coupled with increasing rate of chronic cardiovascular, oncology and neurology diseases, there is tremendous growth potential in this market, especially in developing nations. Similarly, the use of radiolabeled isotopes with peptides and monoclonal antibodies has opened new boulevards for the growth of the global radiopharmaceuticals market. Many radiopharmaceuticals use technetium-99m (Tc-99m) that has many useful properties of gamma-emitting tracer nuclide. Radiopharmaceuticals are majorly used to diagnose cancer, tumors, biliary tract blockage, bone diseases, bone marrow diseases, brain diseases, colorectal disease, disorders of iron metabolism and absorption, heart disease, heart muscle damage (infarct), impaired flow of cerebrospinal fluid in the brain, kidney diseases, liver diseases, lung diseases, parathyroid diseases, parathyroid cancer, pernicious anemia, improper absorption of vitamin B12 from intestines, red blood cell diseases, salivary gland diseases, spleen diseases, stomach and intestinal bleeding, stomach problems, tear duct blockage, thyroid diseases, thyroid cancer and urinary bladder diseases. This may be given to the patient in a number of ways, for e.g. they may be given through the mouth, through injections or placed into the eye or into the bladder. It is a small treatment, which includes use of simple substances containing radioactive isotopes. While treating cancer, these radioactive agents are taken up in the cancerous area to destroy the affected tissues. It works effectively by targeting the areas in the body where the cancer is present. Individuals are suggested to intake radiopharmaceuticals only under the direct supervision of a doctor. This report analyses the global scenario of the radiopharmaceuticals market, discussing detailed overview and market figures. The research report analyses the industry growth rate, industry capacity, and industry structure. The report analyses the historical data, and forecasts the radiopharmaceuticals market size, production forecasts along with key factors driving and restraining the market. The report also analyzes the radiopharmaceuticals market by generators and by further classifying them in terms of medical isotopes, their applications, end users and geographic distribution. The medical isotopes category covers major isotopes used in SPECT and PET imaging like technetium, thallium, gallium, rhenium, yttrium and others. The applications market is further classified into diagnosis and therapy. The end user analysis is done by bifurcation of the market into hospitals and outpatient diagnostic centers. The geography market has been segmented into four major regions - North America, Europe, Asia-Pacific and Rest of the World (RoW). Some of the top radiopharmaceutical companies in the healthcare market are Covidien Plc, Nordion Inc., Lantheus Medical Imaging, IBA Group, Positron Corporation, Cardinal Health, Eckert & Ziegler among others. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the radiopharmaceuticals market as below: Radiopharmaceuticals Market by Generator Types Mo-99/Tc-99m generator Sr-82/Rb-82 generator Ge-68/Ga-68 generator Sr-90/Y-90 generator W-188/Re-188 generator Radiopharmaceuticals Market by Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
End-Users Hospitals & Medical Centers Diagnostic Centers Radiopharmaceuticals Market by Applications Diagnosis Diagnosis by Technique SPECT Technetium (Tc-99m) Thallium (TI-201) Gallium (Ga-67) Iodine (I-123) Rhenium (Re-186) Yttrium (Y-90) Others PET Fludeoxyglucose (18F-FDG) Rubidium (Rb-82) Others (Carbon-11 choline, Nitrogen-13 ammonia) Diagnosis by Indications Oncology Cardiovascular Others (Neurological, Thyroid, Gastrointestinal) Therapy Systemic Oncology Iodine (I-131) Yttrium (90Y) Samarium (Sm-153) Strontium (89Sr) Rhenium (186Re) Lutetium (Lu-177) Erbium (169Er) Others Others (Cardiology, Neurology) Radiopharmaceuticals Market by Geography North America Europe Asia-Pacific Rest of the World (RoW)
table Of Contents
chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology
chapter 2 Executive Summary
chapter 3 Global Radiopharmaceuticals Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 Radiopharmaceutical-based Cancer Therapy 3.2.2 Growing Preference For Disease-targeted Therapy 3.2.3 Increasing Awareness Of Accurate Diagnosis 3.2.4 Expanding Molecular Imaging Applications 3.3 Market Restraints 3.3.1 Strict Regulatory Guidelines For Production, Storage And Usage 3.3.2 Worldwide Supply Shortages 3.3.3 Price Sensitivity And Competitive Alternatives 3.4 Market Opportunities 3.4.1 Increasing Demand For Accurate Diagnosis And Treatment, Particularly In Emerging Markets 3.4.2 Radiopharmaceutical-based Personalized Therapy
chapter 4 Market Definition & Supply Chain Analysis Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
4.1 Market Definition 4.2 Radiopharmaceutical Production : A Global Perspective 4.3 Supply Chain Analysis
chapter 5 Global Radiopharmaceutical Generators Market 5.1 Overview 5.1.1 Global Radiopharmaceutical Generators Market, By Revenue, 2010-2018 (usd Million) 5.2 Mo-99/tc-99m Generators 5.3 Sr-82/rb-82 Generators 5.4 Ge-68/ga-67,68 Generators 5.5 Sr-90/y-90 Generators 5.6 W-188/re-188 Generators
chapter 6 Global Radiopharmaceuticals Market, By End-user Groups 6.1 Overview 6.1.1 Global Radiopharmaceuticals Market By End Users, By Revenue, 2010-2018 (usd Million) 6.2 Hospitals And Medical Centers 6.2.1 Global Radiopharmaceuticals Market By End User Groups : Hospitals And Medical Centres, 2010 – 2018 (usd Million) 6.3 Outpatient Diagnostic Centers 6.3.1 Global Radiopharmaceuticals Market By End User Groups: Diagnostic Centres, 2010 – 2018 (usd Million)
chapter 7 Global Radiopharmaceuticals Market, By Applications 7.1 Overview 7.2 Radiopharmaceuticals For Diagnosis 7.2.1 Overview 7.2.2 Radiopharmaceuticals For Diagnosis, By Technique 7.2.2.1 Single-photon Emission Computed Tomography (spect) 7.2.2.1.1 Comparative Analysis: Spect Radioisotopes Market, 2011 & 2018 (%) 7.2.2.1.2 Technetium (tc-99m) 7.2.2.1.3 Thallium (tl-201) 7.2.2.1.4 Gallium (ga-67) 7.2.2.1.5 Iodine (i-123) 7.2.2.1.6 Rhenium (re-186) 7.2.2.1.7 Yttrium (y-90) 7.2.2.1.8 Others 7.2.2.2 Positron Emission Tomography (pet) 7.2.2.2.1 Comparative Analysis: Pet Radioisotopes Market, 2011 & 2018 (%) 7.2.2.2.2 Fludeoxyglucose (18f-fdg) Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
7.2.2.2.3 Rubidium (rb-82) 7.2.2.2.4 Others (carbon-11 Choline, Nitrogen13 Ammonia) 7.2.3 Radiopharmaceuticals For Diagnosis, By Indications 7.2.3.1 Oncology 7.2.3.2 Cardiovascular 7.2.3.3 Others (neurological, Thyroid, Gastrointestinal) 7.3 Radiopharmaceuticals For Therapy 7.3.1 Overview 7.3.2 Oncology (systemic Therapy) 7.3.2.1 Comparative Analysis: Systemic Therapy Radioisotopes Market, 2011 & 2018 (%) 7.3.2.2 Iodine (i-131) 7.3.2.3 Yttrium (y-90) 7.3.2.4 Samarium (sm-153) 7.3.2.5 Strontium (sr-89) 7.3.2.6 Rhenium (186re) 7.3.2.7 Lutetium-177 (lu-177) 7.3.2.8 Erbium-169 (169er) 7.3.2.9 Others 7.3.3 Other Applications In Therapy (cardiology, Neurology) 7.4 Theranostics
chapter 8 Global Radiopharmaceuticals Market, By Geography 8.1 Overview 8.2 North America 8.2.1 North America Radiopharmaceuticals Market - Diagnosis And Systemic Therapy, 2010-2018 (usd Million) 8.2.2 North America Diagnosis Radiopharmaceuticals Market 2010-2018 (usd Million) 8.3 Europe 8.3.1 Europe Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (usd Million) 8.3.2 Europe Diagnosis Radiopharmaceuticals Market 2010-2018 (usd Million) 8.4 Asia-pacific (apac) 8.4.1 Asia-pacific Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (usd Million) 8.4.2 Asia-pacific Diagnosis Radiopharmaceuticals Market 2010-2018 (usd Million) 8.5 Rest Of The World (row) 8.5.1 Row Radiopharmaceuticals Market- Diagnosis And Systemic Therapy, 2010-2018 (usd Million) 8.5.2 Row Diagnosis Radiopharmaceuticals Market 2010-2018 (usd Million)
chapter 9 Market Share Analysis By Key Players 9.1 Radiopharmaceuticals Market 9.2 Generators Market
Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
chapter 10 Recommendations 10.1 Identification And Elimination Of Barriers 10.2 Development Of Total Solutions 10.3 Investing In Emerging Markets 10.4 Entering Monopoly Markets
chapter 11 Company Profiles 11.1 Cardinal Health Inc. 11.1.1 Company Overview 11.1.2 Financial Overview 11.1.3 Business Strategies 11.1.3.1 Mergers And Acquisitions 11.1.3.2 External Funding 11.1.3.3 Incorporation Of Advanced Technologies To Support Business Development 11.1.4 Product Portfolio 11.1.5 Recent Developments 11.2 Covidien Plc 11.2.1 Company Overview 11.2.2 Product Portfolio 11.2.3 Financial Overview 11.2.4 Strategic Overview 11.2.4.1 Mergers And Acquisitions 11.2.4.2 Approvals 11.2.5 Recent Developments 11.3 Ge Healthcare 11.3.1 Company Overview 11.3.2 Product Portfolio 11.3.3 Financial Overview 11.3.4 Strategic Overview 11.3.4.1 Mergers And Acquisitions 11.3.5 Recent Developments 11.4 Iba Group 11.4.1 Company Overview 11.4.2 Financial Overview 11.4.3 Product Portfolio 11.5 Lantheus Medical Imaging 11.5.1 Company Overview 11.5.2 Financial Overview 11.5.3 Business Strategies 11.5.3.1 Rigorous Research And Development Initiatives 11.5.3.2 Selling Generic Products To Maintain Market Share 11.5.4 Product Portfolio Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
11.5.4.1 Recent Developments 11.6 Monrol Nuclear Products, Inc. 11.6.1 Company Overview 11.6.2 Product Portfolio 11.6.3 Strategic Overview 11.6.3.1 Mergers And Acquisitions 11.6.3.2 Collaborations 11.6.4 Recent Developments 11.7 Nordion, Inc. 11.7.1 Company Overview 11.7.2 Product Portfolio 11.7.3 Financial Overview 11.7.4 Strategic Overview 11.7.4.1 Contracts And Agreements 11.7.4.2 Divestiture 11.7.5 Recent Developments 11.7.5.1 New Product Launch 11.8 Ntp Radioisotopes (pty) Ltd 11.8.1 Company Overview 11.8.2 Financial Overview 11.8.3 Business Strategies 11.8.3.1 Media Campaigns As A Brand Management Tool 11.8.3.2 Business Expansion Through Partnerships, Collaborations And Alliances 11.8.4 Product Portfolio 11.8.5 Recent Developments 11.9 Polatom 11.9.1 Company Overview 11.9.2 Financial Overview 11.9.3 Business Strategies 11.9.3.1 Maintaining An Extensive Network Of Distributors 11.9.4 Product Portfolio 11.9.5 Recent Developments 11.10 Positron Corporation 11.10.1 Company Overview 11.10.2 Product Portfolio 11.10.3 Financial Overview 11.10.4 Strategic Overview 11.10.4.1 Contracts And Agreements 11.10.4.2 Collaborations 11.10.5 Recent Developments 11.10.5.1 Grants And Licenses 11.10.5.2 Incentives 11.11 Siemens Healthcare Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
11.11.1 Company Overview 11.11.2 Financial Overview 11.11.3 Business Strategies 11.11.3.1 Investing In Emerging Economies 11.11.3.2 Rigorous Research And Development Initiatives 11.11.3.3 Identifying Key Growth Areas And Determining Short Term Goals (agenda 2013) 11.11.3.4 Maintaining An Extensive Suppliers Network 11.11.4 Product Portfolio 11.11.5 Recent Developments About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact: ResearchMoz 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Blog: http://researchmoz.blogspot.com/ Website: http://www.researchmoz.us/
Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018